ResultsIQ

ResultsIQ › Latest results › Natural Capsules Limited

Natural Capsules Limited Q4 FY25 results deck summary

NSE: NATCAPSUQ · BSE: 524654

Results deck of 31 May 2025, summarised by AI from the filing.

Q4FY25 revenue ₹44.97 cr, up 11.81% Y-o-Y; FY26 topline expected to increase on HPMC capsules after US imposed 88% duty on Chinese HPMC.

Key takeaways

  1. Q4FY25 revenue Revenue from operations was ₹44.97 cr in Q4FY25, up 11.81% Y-o-Y from ₹40.22 cr in Q4FY24.
  2. FY26 guidance Management expects increase in topline in FY26 driven by HPMC capsules, which command higher realisations and offer superior profitability.
  3. US duty change US imposed 88% duty on Chinese HPMC capsules vs 14% on Indian HPMC capsules, creating opportunities for Indian manufacturers.
  4. HPMC driver Marked increase in enquiries from US customers; management reasonably confident of rapid scale-up of HPMC business in US over current financial year.

Original filing on BSE

Natural Capsules Limited Q1 FY27 results

As filed: Revenue ₹48.7 cr (+8% year on year), EBITDA ₹1.1 cr (+12% year on year), PAT −₹5.7 cr, EBITDA margin 2.3% (+8 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹58.5 cr (+30% year on year), EBITDA ₹1.3 cr (−73% year on year), PAT −₹5.0 cr (−300% year on year), EBITDA margin 2.3% (−884 bps). Score 20 of 100, Below trend. EBITDA margin fell 884 bps year on year. Consolidated profit -598% but standalone +84%. Not enough history for a trend yet: scored on growth alone. Share price after the results: −6.5% in 29 days (Nifty 500: +0.6%).
  • Q3 FY26: Revenue ₹34.2 cr, EBITDA ₹1.9 cr, PAT ₹0.4 cr, EBITDA margin 5.5%. Not scored. No result for the same quarter last year. Share price after the results: −10.5% in 28 days (Nifty 500: −8.2%).
  • Q2 FY26: Revenue ₹45.0 cr, EBITDA ₹5.0 cr, PAT ₹3.0 cr, EBITDA margin 11.1%. Not scored. No result for the same quarter last year. Share price after the results: −11.6% in 29 days (Nifty 500: −0.4%).
  • Q1 FY26: Revenue ₹44.0 cr, EBITDA ₹4.0 cr, PAT ₹3.0 cr, EBITDA margin 9.1%. Not scored. No result for the same quarter last year. Share price after the results: −7.2% in 30 days (Nifty 500: 0.0%).
  • Q4 FY25: Revenue ₹44.0 cr, EBITDA ₹5.0 cr, PAT ₹3.0 cr, EBITDA margin 11.4%. Not scored. No result for the same quarter last year. Share price after the results: −2.2% in 29 days (Nifty 500: +3.3%).

Past price moves after results do not indicate future moves. Not a recommendation.

Natural Capsules Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.